Ipilimumab/nivolumabMyasthenia gravis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1917卷 / 1期

关键词：

D O I：

10.1007/s40278-022-20196-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：325 / 325

相关论文

共 50 条

[1] Ipilimumab/nivolumabMyasthenia gravis: case report
Reactions Weekly, 2020, 1835 (1) : 227 - 227
[2] Ipilimumab/nivolumabMyasthenia gravis: case report
Reactions Weekly, 2023, 1963 (1) : 302 - 302
[3] Ipilimumab/nivolumabMyasthenia gravis like syndrome: case report
Reactions Weekly, 2019, 1765 (1) : 201 - 201
[4] Ipilimumab/nivolumabMyasthenia gravis, hepatitis and thyroiditis: case report
Reactions Weekly, 2020, 1810 (1) : 122 - 122
[5] Ipilimumab/nivolumabMyasthenia gravis, myositis, and sensorimotor polyneuropathy: case report
Reactions Weekly, 2018, 1686 (1) : 214 - 214
[6] NivolumabMyasthenia gravis: case report
Reactions Weekly, 2017, 1672 (1) : 202 - 202
[7] Ipilimumab/nivolumabMyasthenia gravis (first report for nivolumab) progressing to respiratory failure : case report
Reactions Weekly, 2015, 1564 (1) : 128 - 128
[8] NivolumabMyasthenia gravis: case report
Reactions Weekly, 2020, 1788 (1) : 177 - 177
[9] NivolumabMyasthenia gravis: case report
Reactions Weekly, 2017, 1647 (1) : 222 - 222
[10] NivolumabMyasthenia gravis: case report
Reactions Weekly, 2019, 1774 (1) : 241 - 241

← 1 2 3 4 5 →